Skip to main content
2025 STS Annual Meeting Main banner
Back

Adult Cardiac

STS/EACTS: Tricuspid Valve Disease: No Longer the Forgotten Valve

Radical and Revolutionary: Recent Tricuspid Transcatheter Valve Trials and What They Mean for Surgeons

Friday, January 24, 2025
2:43pm – 2:51pm PT
Location: 403A

    Invited Speaker(s)

  • Vinod H. Thourani, MD

    Marcus Chairman of Cardiovascular Surgery
    Piedmont Heart Institute and Piedmont Healthcare
    Atlanta, Georgia, United States

    Disclosure(s): Abbott Vascular: Consultant (Ongoing); AtriCure Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic Cardiovascular: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Disclosure(s):
Vinod H. Thourani, MD: Abbott Vascular: Consultant (Ongoing); AtriCure Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic Cardiovascular: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)